Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Researchers identified a new hair loss pattern called "sisaipho type," where hair is lost across the scalp except around the edges.

Malassezia Folliculitis and truncal acne are different conditions requiring different treatments.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Hair follicles help wounds heal faster, especially in active growth phase skin.

Targeting Sirt1 can reduce androgen levels and slow glioblastoma growth.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

A five-year-old girl has a harmless, unchanging bald patch on her scalp.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

The study found that stem cells and neutrophils are important for regenerating hair follicle structures in mice.

Activating Nrf2 can improve wound healing by increasing hair follicle stem cells.

Cell processes depend on time-of-day and protein complex flexibility for skin health.

Alopecia areata in children is often linked to genetics, autoimmune issues, and stress, and is treated with corticoids or PUVA therapy.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Pharmacophore models can predict liver toxicity and central nervous system toxicity, but they have limitations and specific requirements.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Mitochondrial problems in diabetic nerve damage might cause pain by lowering the production of certain nerve-related steroids.

SJS and TEN can cause long-term organ damage and psychological issues beyond skin and eye problems.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.